TE
Therapeutic Areas
Astrocyte Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AST-004 | Concussion (mild Traumatic Brain Injury) | Phase 2 |
| Unnamed programs | Traumatic Brain Injury (TBI) | Preclinical |
Leadership Team at Astrocyte Pharmaceuticals
WS
William S. Korinek
Co-Founder and Chief Executive Officer
JD
James D. Lechleiter
Co-Founder and Advisor
KS
Kevin Sheth
Advisor
LM
Lisa Manna
Vice-President of Clinical Development Operations
RB
Russell B. Poe
Head of Chemistry and Manufacturing Controls (CMC)
SA
Stanley A. Roberts
Head of Non-Clinical Safety Assessment
JL
Jeffrey L. Ives
Director
JM
Jeffrey M. Arnold
Director
JS
Jackson Streeter
Director
CG
Christine Gallagher
Director